Working across sectors
Engaging stakeholders across health, justice, law enforcement, academia and the philanthropic worlds.
- The Foundation, in partnership with the Harvard Global Health Institute and the London School of Hygiene and Tropical Medicine, brought together stakeholders to a conference at the Wellcome Trust, on 28 March 2018, to explore global priorities.
- The stakeholders spanned English- and French-speaking countries and institutions.
Medicines that Lie Symposium
Engaging global stakeholders
- The stakeholders confirmed that it was now crucial to tackle this issue, which affects every country around the world but which in many low-income countries has become a grave public health crisis.
- It is particularly acute in Sub-Saharan where between 30% and 60% of the medicines in circulation are believed to be substandard or counterfeit.
The Time is Now
- Following the 2017 World Health Assembly agreement among national governments, there was no longer an excuse for inaction.
- Acknowledging that this is a multi-faceted problem. The policy solutions, including improved regulation, stronger legal frameworks, stricter enforcement and tougher penalties, need to reflect this reality. Therefore, these are issues that will require the engagement of not only health ministries but also justice and interior ministries.
The panel of speakers at the symposium.
Michael Deats, Vigilance, Spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products group lead, WHO Headquarters; Dr Ashish Jha, Director of Harvard Global Health Institute; Mrs Pauline Latham, Conservative MP for Mid Derbyshire; Sir David Richmond, Former CEO of the Brazzaville Foundation.